Article
Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study.
Journal of gastrointestinal cancer - 1 Jun 2021
Garcia-Pardo Miguel, Ortega Laura, Fernández-Aceñero María Jesús, García Alfonso Pilar, Martín Miguel, Muñoz Andrés J
Abstract excerpt
PURPOSE: Cholangiocarcinoma (CCA) is an aggressive biliary tract malignancy and overall prognosis remains poor, with a median survival of less than 24 months. Sequencing studies have revealed a high prevalence of genomic alterations in CCA, with multiple potential therapeutic targets. Next-generation sequencing (NGS) can identify actionable mutations such as FGFR, IDH, BRAF, ERBB2, ROS1, or microsatellite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
